Who are Prophylactic platelet transfusion's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Red Blood Cell Transfusion, Human albumin, FFP and Cryoprecipitate, Humanalbumin 5%, Pathogen-Reduced Plasma, Transfusion of blood products.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/prophylactic-platelet-transfusion.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Prophylactic platelet transfusion — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prophylactic platelet transfusion (Prophylactic platelet transfusion) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Blood product. Area: Hematology.

phase 3 Blood product Hematology Biologic Live · refreshed every 30 min

Target snapshot

Prophylactic platelet transfusion (Prophylactic platelet transfusion) — Technische Universität Dresden. Prophylactic platelet transfusion involves administering platelets to prevent bleeding in patients with low platelet counts.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Prophylactic platelet transfusion TARGET	Prophylactic platelet transfusion	Technische Universität Dresden	phase 3	Blood product
Red Blood Cell Transfusion	Red Blood Cell Transfusion	Rutgers, The State University of New Jersey	marketed	Blood product / Cellular therapy
Human albumin	Human albumin	Hamad Medical Corporation	marketed	Plasma volume expander; blood product derivative
FFP and Cryoprecipitate	FFP and Cryoprecipitate	The University of Texas Health Science Center, Houston	marketed	Blood product / Hemostatic agent
Humanalbumin 5%	Humanalbumin 5%	Medical University of Vienna	marketed	Plasma volume expander; blood product derivative
Pathogen-Reduced Plasma	Pathogen-Reduced Plasma	Coalition for National Trauma Research	marketed	Blood product / Plasma derivative
Transfusion of blood products	Transfusion of blood products	Fundacion Clinica Valle del Lili	marketed	Blood product transfusion

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Blood product class)

Asan Medical Center · 1 drug in this class
Johns Hopkins University · 1 drug in this class
Technische Universität Dresden · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Prophylactic platelet transfusion — Competitive Intelligence Brief. https://druglandscape.com/ci/prophylactic-platelet-transfusion. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing